Two directors appointed to the board of 'The Irish Times'
The media group, which includes the Irish Examiner and The Echo titles, along with MyHome.ie and RIP.ie, has appointed David Martin and Mikie Sheehan after non-executive directors Clare Duignan and Rhona Murphy retired from the board in June.
Mr Sheehan has served as chief financial officer to the group since 2020.
He joined the Examiner Group (formerly Landmark Media) in 2013 and has held a number of senior roles, including that of interim managing director of the Irish Examiner and The Echo.
He began in his career at Deloitte where he qualified as a chartered accountant following completion of a BSc in accounting from University College Cork.
Mr Martin is a fractional executive, strategy consultant, and a former senior director at Google, where he played a leading role in the development of Google Maps global operations.
David Martin is a fractional executive, strategy consultant, investor, and a former senior director at Google.
With a background in electronic engineering, he has worked with Toshiba, with McKinsey as a management consultant, and was head of strategy at eircom (now eir).
Mr Martin was a founding board member of Science Gallery International.
Welcoming the appointments, The Irish Times Group managing director Deirdre Veldon said: 'As the media industry faces a host of new challenges from technology and changes in consumer behaviour, it's a good time to introduce innovative thinking and digital expertise to The Irish Times to help us navigate this dynamic landscape.'
Read More
Salaries on the rise for financial advisors due to shortfall in skills
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
2 days ago
- Irish Examiner
MSD won't close Irish sites as part of $3bn cutbacks
Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. MSD yesterday announced a global cost-cutting exercise as it prepares for generic competition to its Irish-manufactured cancer drug Keytruda, the world's best-selling medicine, which is predominantly made in Ireland. The company will cut administrative, sales and research jobs, with increased focus on the US market. It has not said where the roles will be lost or if any Irish workers will be among those affected. However, a spokesperson told the Irish Examiner: "The restructuring announced today does not include site closures in Ireland." MSD employs more than 3,000 people at eight locations in Ireland. These include MSD Brinny in Co Cork specialising in development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines; three facilities in Dublin (MSD Biotech, MSD Blackrock, and MSD Red Oak North); MSD Carlow; MSD Dunboyne in Co Meath; MSD Ballydine in Co Tipperary, the company's first Irish site; and MSD Dundalk, the former WuXi Vaccines sites acquired in January. The cost cuts will include $1.7bn (€1.47bn) in annual savings from the elimination of certain administrative, sales and R&D positions, MSD said. The company expects the restructuring to be completed by the end of 2027, the year before Keytruda's key patents expire and the drug faces US government price cuts. The company said it plans to reinvest the savings into developing new drugs and launching new products. EU-branded medicines will face 15% import tariffs under the new transatlantic trade deal agreed between the European bloc and the US at the weekend. Like many other pharmaceutical firms based in Ireland, MSD had stockpiled doses of Keytruda manufactured in Ireland, to protect itself from tariffs imposed in 2025. MSD previously disclosed plans to invest more than $9bn (€7.78bn) in US manufacturing over the next four years, part of an effort to make more of its medicines in the US. The company reiterated that it expects to spend $200m (€172m) on tariffs in 2025, a number that reflects levies already in place and doesn't account for future tariffs on pharmaceuticals.
Irish Examiner
4 days ago
- Irish Examiner
EU-US trade deal criticised by German business leaders and French minister
The EU-US trade deal, clinched in a ballroom at Donald Trump's golf resort in Scotland on Sunday, has been criticised by France's prime minister and business leaders across Germany. The deal, which will impose 15% tariffs on almost all European exports to the US including cars, ends the threat of a punitive 30% import duties being imposed on Mr Trump's August 1 deadline for a deal, but it is a world apart from the zero-zero import and export tariff the EU offered initially. It also means European exporters to the US will face more then triple the average 4.8% tariff now in force, with negotiations to continue on steel, which is still facing a 50% tariff, aviation, and a question mark over future barriers to pharmaceutical exports. The deal has been cautiously welcomed on the Irish side, with Government sources saying it provides certainty to businesses. One senior source said 'nobody was jumping with joy' over the deal due to baseline tariffs, but that it did provide certainty to businesses. Reacting to the deal, Taoiseach Micheál Martin said it brought 'clarity and predictability to the trading relationship between the EU and the US'. 'That is good for businesses, investors and consumers. It will help protect many jobs in Ireland,' Mr Martin said. 'We will now study the detail of what has been agreed, including its implications for businesses exporting from Ireland to the US, and for different sectors operating here. However, Mr Martin said the baseline tariff would make trade between the EU and US 'more expensive and more challenging'. France's prime minister, François Bayrou, said Europe had submitted to the US, on a 'dark day' for the union. 'It is a dark day when an alliance of free peoples, gathered to affirm their values and defend their interests, resolves to submission,' Bayrou posted on X. The German chancellor, Friedrich Merz, rapidly hailed the deal, saying it avoided 'needless escalation in transatlantic trade relations' and averted a potentially damaging trade war. German exporters were less enthusiastic. The powerful BDI federation of industrial groups said the accord would have 'considerable negative repercussions', while the country's VCI chemical trade association said the accord left rates 'too high'. It is also clear that the US tariff of 15% on automotive products will place a burden on German automotive companies in the midst of their transformation, hitting sales and profits. The president of the car industry federation VDA, Hildegard Müller, said it was 'fundamentally positive' that a framework deal was agreed but warned of huge costs to come. European stock markets hit a four-month high at the start of trading on Monday, amid relief that a deal had been reached. Germany's Dax jumped by 0.86%, and France's Cac 40 index rose by 1.1%. France's minister for Europe, Benjamin Haddad, said on Monday that the agreement would provide 'temporary stability … but it is unbalanced'. Victory for Trump The German bank Berenberg said the deal brought to an end the 'crippling uncertainty' but said it was a victory for Mr Trump. 'It is great to have a deal. In two major respects, however, the outcome remains much worse than the situation before Trump started his new round of trade wars early this year,' said Holger Schmieding, Berenberg's chief economist. 'The extra US tariffs will hurt both the US and the EU. For Europe, the damage is mostly frontloaded,' Mr Schmieding said in a note to clients on Monday morning. 'The deal is asymmetric. The US gets away with a substantial increase in its tariffs on imports from the EU and has secured further EU concessions to boot. In his apparent zero-sum mentality, Trump can claim that as a 'win' for him,' he added. The Italian bank UniCredit also said Mr Trump had got the better out of the EU. 'Is this a good deal for the EU? Probably not. The outcome is heavily asymmetrical, and it leaves US tariffs on imported EU goods at much higher levels than EU tariffs on imports from the US,' UniCredit said in a note to clients. '15% is not to be underestimated, but it is the best we could get,' the European Commision president Ursula von der Leyen acknowledged. Initially the EU had tried to hardball the US by threatening but pausing €21bn worth of retaliatory measures in April, and adding another list of €73bn-worth of US imports that would be taxed earlier this month. But it pivoted to a quick UK-style deal after the Nato summit in June, swapping a comprehensive trade deal for security and defence promises from Mr Trump. By contrast, China, which threatened the US with a cascade of punitive tariffs, is still negotiating with Mr Trump, who over the weekend froze technology transfer restrictions to create space for a deal with Beijing. Berenberg said the deal would affect the German economy, but the decline in growth would be offset by the Bundestag's recent growth stimulus package, it added. The EU had pushed for a compromise on steel that could allow a certain quota into the US before tariffs would apply. Mr Trump appeared to rule that out, saying steel was 'staying the way it is', but Ms von der Leyen insisted later that 'tariffs will be cut and a quota system will be put in place' for steel. He also ruled out a carve-out for pharmaceuticals but later Ms von der Leyen said the 15% tariff would apply to EU medicine exports and that any other tariffs were up to the US president. The EU is now subject to a 25% levy on cars, 50% on steel and aluminium, and an across-the-board tariff of 10%, which Washington had threatened to increase to 30% in a no-deal scenario. The bloc had been pushing hard for tariff carve-outs for critical industries from aircraft to spirits, and its car industry, crucial for France and Germany, is already reeling from the levies imposed so far. The Guardian
Irish Examiner
5 days ago
- Irish Examiner
Incomplete structures in Kilmore Road development facing demolition
Cork City Council spent almost €2.5m on a controversial and unfinished 24-house development on the city's northside, but it is unclear how many of the incomplete structures are now being demolished. In March 2020, a private contractor began work on 24 houses on Kilmore Rd in Knocknaheeny before work ground to a halt a few months later in what Cork City Council described as 'a complex contractual dispute'. The houses were being built under phase 2c of the Cork Northwest Quarter Regeneration (CNWQR) project, a huge multi-annual, phased regeneration project which began in the Knocknaheeny and Hollyhill area more than a decade ago. The CNWQR, adopted by the council in November 2011, involves the demolition of 450 houses and the design and construction of more than 600 new homes. Last year, the council resolved its dispute with the Phase 2c contractors, and reissued the tender for the project, costed at an estimated €5m. Works eventually began this summer under a new contractor. At a recent council meeting, Sinn Féin's Kenneth Collins asked the total sum paid to the original contractor and 'the percentage amount of work complete that will require demolition and the cost of this demolition'. He was told the original contractor had been paid €2,452,317, ex Vat, in May 2024, and '0% of the works complete will require demolition'. Rectification and completion works Asked by the Irish Examiner how this claim squared with photographic evidence of current demolition work, a council spokesperson clarified that the council had engaged a contractor to undertake 'rectification and completion works on the 24-unit housing development at Kilmore Road Lower". 'These works include the demolition and taking down of incomplete works. 'Works that have been certified as complete which were undertaken by the initial contractor do not require demolition,' they said. When asked how much of the development was not certified as complete, a spokesperson admitted that, in fact, none of the 24 homes had been completed by the original contractor. 'Zero homes are certified as complete,' the spokesperson said. 'We are still within a construction contract and practical completion of the contract has not been reached.' In a subsequent email, they said not all of the initial works were being demolished but they did not immediately respond when asked how many of the buildings were being retained. Almost two weeks after his initial question, Mr Collins said he was again asking how much of the original work was being demolished. 'I can't understand why we can't get a straight answer, but first we're told 0% required demolition, then they say it's 0% of completed buildings and now they say none of the buildings were completed, but some aren't being demolished,' he said. So how many of the buildings are being demolished? Why can't the council answer a simple question? 'This is a long running saga. The people of Knocknaheeny want these homes built. 'They've lived opposite and beside a building site for years on end. The council have broken commitment after commitment when it came to this site. In its most recent statement, a council spokesperson said: 'Works undertaken by the initial contractor would have constituted approximately 55% of the project. 'The new contractor is now at approximately 60% (plus c5% on the initial signed off works) completion overall as they have recently commenced. 'As per previous all works signed off in that approximately 55% are to be retained. A minor percentage of works not signed off were not retained.'
